triple glp 1 gip glucagon receptor agonist Courtesy ref no. 43-Schematic demonstrating the working principle, parkinson's disease triple agonist glp-1

Six models were fit with BrAC, perceived drunkenness, alcohol craving, appetite, blood glucose, and nausea scores as dependent variables, respectively (Supplemental Table 2)

Food Funct

2018 doi: 10.1016/j.molmet.2018.06.015

A 2025 Stanford University interview with psychiatrist Anna Lembke touches on positive connections between the dopamine-stabilizing effects of GLP-1 medications on food addictions and the similar needs of patients with other drug addiction issues

This method not only strengthens the evidence for the observed associations but also highlights GLP-1RAs as promising candidates for repurposing in the treatment of psychiatric and neurodevelopmental conditions